Case Study: Ipsen Biopharmaceuticals achieves nationwide policy visibility and streamlined government affairs with FiscalNote

Global Biopharmaceutical Leader Powers its US Policy Strategy with FiscalNote

Ipsen, a global biopharmaceutical leader focused on oncology, neuroscience, and rare disease, faced the challenge of managing an increasingly complex U.S. government affairs landscape. The team needed to monitor and prioritize hundreds of state-level bills and regulations—on issues like price transparency, PBM reform, government insurance, taxes, and environment—stay ahead of fast-moving trends across all 50 states, and track implementation and regulatory changes to avoid being caught off guard.

By combining FiscalNote’s technology with its Professional Services policy experts, Ipsen receives daily updates, custom weekly reports, and bill-level analysis, plus predictive signals on likelihood of passage and tools to track amendments and regulatory implementation. The solution streamlined monitoring and prioritization, improved internal reporting and stakeholder briefings, safeguarded compliance, and enabled Ipsen to proactively target priority markets—powering more effective, growth-oriented state government affairs.

Ipsen Biopharmaceuticals

John Valenti

Head of State Government Affairs and Policy